MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI.

It is developed for new molecules and the life cycle management of inhaled therapies.

In February 2017, MRX003, was given the nod by the FDA as a suitable generic device with which to file a 505j ANDA of Spiriva HandiHaler (tiotropium).

Capsule DPI


MRX003 Detail Shot
MRX003 Brochure

MRX003 Brochure

To download our brochure for MRX003 please enter your email address.

Get in touch with us to find out about terms of access and pricing.

We use cookies only for marketing analytics